Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Ptprq has multiple forms that change during inner ear development.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Blocking Prostaglandin D₂ may help treat hair loss.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Certain VDR gene changes can affect melanoma risk.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

Simple centrifugation with calcium gluconate boosts PDGF-BB release in PRP.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Dermal papilla cells mainly drive blood vessel growth in hair follicles.

Gefitinib can cause scalp skin issues and permanent hair loss.

rPanglaoDB helps study rare cell types by merging RNA data, confirming fibrocytes' role in healing.

Valproic acid and crocin together boost cell growth and may help treat nerve injuries.

Platelet-rich plasma therapy helps heal skin ulcers and stimulates hair growth in dermatology.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Vitamin D receptor mutations can cause alopecia by affecting hair growth genes.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

A Pomeranian dog had rickets due to a new gene mutation, leading to severe symptoms and euthanasia.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.